FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2062970882> ?p ?o ?g. }

• W2062970882 endingPage "280" @default.
• W2062970882 startingPage "275" @default.
• W2062970882 abstract "Dysregulated fibroblast proliferation is thought to play an important role in the progression of bronchiolitis obliterans (BO) after lung transplantation. Augmented immunosuppression is often used to treat BO. We investigated the effect of methylprednisolone (mPRED), cyclosporine A (CsA), tacrolimus (FK506), azathioprine (AZA), mycophenolate mofetil (MMF), and everolimus (rapamycin derivative [RAD]) on the proliferative capacity of fibroblasts cultured from transbronchial biopsies of lung transplant recipients.Primary cultures of human lung fibroblasts were obtained from 14 transbronchial biopsies of lung transplant recipients. Subconfluent cells were serum starved for 24 hr followed by growth stimulation in the presence or absence of the respective drug in six concentrations ranging as follows: 0.01 to 100 mg/L for mPRED; 0.01 to 50 mg/L for CsA and AZA; 0.001 to 5 mg/L for FK506 and MMF; and 0.00001 to 1 mg/L for RAD. Proliferation was quantified by [3H]thymidine incorporation and direct cell count. A toxic drug effect was excluded by trypan blue.Drug concentrations (mg/L) causing a 50% inhibition of fibroblast proliferation were mPRED 4; CsA 20; FK506 0.3; AZA 7; MMF 0.3; and RAD 0.0006. Drug concentrations (mg/L) causing inhibition of fetal bovine serum-induced proliferation were mPRED 60; CsA 45; FK506 3; AZA 35; MMF 1; and RAD 0.003.RAD and MMF were the most potent antifibroproliferative drugs and were effective at concentrations achieved clinically, supporting their use for the treatment of patients with early BO. Our method holds promise as an in vitro model to assess the likely in vivo responses of human lung fibroblasts to specific immunosuppressive drugs." @default.
• W2062970882 created "2016-06-24" @default.
• W2062970882 creator A5012153828 @default.
• W2062970882 creator A5016801893 @default.
• W2062970882 creator A5018343814 @default.
• W2062970882 creator A5021433705 @default.
• W2062970882 creator A5036921698 @default.
• W2062970882 creator A5040800860 @default.
• W2062970882 creator A5059183806 @default.
• W2062970882 creator A5067952145 @default.
• W2062970882 creator A5077426550 @default.
• W2062970882 date "2004-01-01" @default.
• W2062970882 modified "2023-10-16" @default.
• W2062970882 title "Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation1" @default.
• W2062970882 cites W1599972517 @default.
• W2062970882 cites W1969689325 @default.
• W2062970882 cites W1970185346 @default.
• W2062970882 cites W1973989691 @default.
• W2062970882 cites W1980245970 @default.
• W2062970882 cites W1985478785 @default.
• W2062970882 cites W1986382397 @default.
• W2062970882 cites W2004876902 @default.
• W2062970882 cites W2008941127 @default.
• W2062970882 cites W2022019494 @default.
• W2062970882 cites W2022850278 @default.
• W2062970882 cites W2023012220 @default.
• W2062970882 cites W2026351725 @default.
• W2062970882 cites W2050544650 @default.
• W2062970882 cites W2069981675 @default.
• W2062970882 cites W2091469493 @default.
• W2062970882 cites W2097086954 @default.
• W2062970882 cites W2106201185 @default.
• W2062970882 cites W2115915333 @default.
• W2062970882 cites W2124156250 @default.
• W2062970882 cites W2155312039 @default.
• W2062970882 cites W2156709019 @default.
• W2062970882 cites W2160202789 @default.
• W2062970882 cites W2167087558 @default.
• W2062970882 cites W2168375708 @default.
• W2062970882 cites W2168582542 @default.
• W2062970882 cites W2316067769 @default.
• W2062970882 doi "https://doi.org/10.1097/01.tp.0000101822.50960.ab" @default.
• W2062970882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14742993" @default.
• W2062970882 hasPublicationYear "2004" @default.
• W2062970882 type Work @default.
• W2062970882 sameAs 2062970882 @default.
• W2062970882 citedByCount "101" @default.
• W2062970882 countsByYear W20629708822012 @default.
• W2062970882 countsByYear W20629708822013 @default.
• W2062970882 countsByYear W20629708822014 @default.
• W2062970882 countsByYear W20629708822015 @default.
• W2062970882 countsByYear W20629708822016 @default.
• W2062970882 countsByYear W20629708822017 @default.
• W2062970882 countsByYear W20629708822018 @default.
• W2062970882 countsByYear W20629708822019 @default.
• W2062970882 countsByYear W20629708822020 @default.
• W2062970882 countsByYear W20629708822022 @default.
• W2062970882 countsByYear W20629708822023 @default.
• W2062970882 crossrefType "journal-article" @default.
• W2062970882 hasAuthorship W2062970882A5012153828 @default.
• W2062970882 hasAuthorship W2062970882A5016801893 @default.
• W2062970882 hasAuthorship W2062970882A5018343814 @default.
• W2062970882 hasAuthorship W2062970882A5021433705 @default.
• W2062970882 hasAuthorship W2062970882A5036921698 @default.
• W2062970882 hasAuthorship W2062970882A5040800860 @default.
• W2062970882 hasAuthorship W2062970882A5059183806 @default.
• W2062970882 hasAuthorship W2062970882A5067952145 @default.
• W2062970882 hasAuthorship W2062970882A5077426550 @default.
• W2062970882 hasConcept C126322002 @default.
• W2062970882 hasConcept C185592680 @default.
• W2062970882 hasConcept C202751555 @default.
• W2062970882 hasConcept C203014093 @default.
• W2062970882 hasConcept C2776739411 @default.
• W2062970882 hasConcept C2776760755 @default.
• W2062970882 hasConcept C2777714996 @default.
• W2062970882 hasConcept C2777921159 @default.
• W2062970882 hasConcept C2778033501 @default.
• W2062970882 hasConcept C2778330430 @default.
• W2062970882 hasConcept C2779134260 @default.
• W2062970882 hasConcept C2779699572 @default.
• W2062970882 hasConcept C2780252810 @default.
• W2062970882 hasConcept C2780381497 @default.
• W2062970882 hasConcept C2781448352 @default.
• W2062970882 hasConcept C2909675724 @default.
• W2062970882 hasConcept C2909935303 @default.
• W2062970882 hasConcept C2911091166 @default.
• W2062970882 hasConcept C55493867 @default.
• W2062970882 hasConcept C71924100 @default.
• W2062970882 hasConcept C98274493 @default.
• W2062970882 hasConceptScore W2062970882C126322002 @default.
• W2062970882 hasConceptScore W2062970882C185592680 @default.
• W2062970882 hasConceptScore W2062970882C202751555 @default.
• W2062970882 hasConceptScore W2062970882C203014093 @default.
• W2062970882 hasConceptScore W2062970882C2776739411 @default.
• W2062970882 hasConceptScore W2062970882C2776760755 @default.
• W2062970882 hasConceptScore W2062970882C2777714996 @default.
• W2062970882 hasConceptScore W2062970882C2777921159 @default.
• W2062970882 hasConceptScore W2062970882C2778033501 @default.

• next